Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00314821 · ClinicalTrials.gov registry record · Phase 4
Ropinirole in the Treatment of Bipolar Depression
A Phase 4 study, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00314821 is a Phase 4 study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 40 participants.
The verdict
NCT00314821, a Phase 4 study, has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
To demonstrate efficacy and safety of Requip in in treating bipolar depression.
Interventions
- DRUG ropinirole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-03-17 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00314821
The ClinicalTrials.gov registry entry for NCT00314821 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cambridge Health Alliance, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ropinirole is the first listed.
NCT00314821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00314821 about?
NCT00314821 is a clinical study titled "Ropinirole in the Treatment of Bipolar Depression". To demonstrate efficacy and safety of Requip in in treating bipolar depression.
What is the current status of trial NCT00314821?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2005-09. Estimated completion is 2008-03-17.
What interventions are being tested in trial NCT00314821?
The interventions under investigation include: ropinirole (DRUG).
Who is sponsoring clinical trial NCT00314821?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.